As of 2026-03-27, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (14.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -196.5%.
The range of the Relative Valuation is (14.14) - (14.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 21.0x | 20.2x |
| Forward P/E multiples | 18.2x - 20.3x | 19.6x |
| Fair Price | (14.14) - (14.99) | (14.72) |
| Upside | -192.7% - -198.3% | -196.5% |
| Date | P/E |